scholarly journals Optimum control of TB in the EU by addressing migrant health effectively in an interconnected world

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
D M Koster ◽  
A J Bootsma

Abstract Worldwide, tuberculosis is one of the top 10 causes of death. Although most EU/EEA countries are low-incidence, TB remains a public health issue. In this region, TB predominantly affects vulnerable populations, including migrants (ECDC/WHO, 2019). Since migration has been increasing over the last several decades, the health needs are considerable and merit great attention for several reasons. First, migrants have a right to health. Second, health promotion and disease prevention among migrants contributes to overall public health. Last, healthy migrants contribute to positive development outcomes (WHO, 2016) (IOM, 2017). In order to meet the health needs of migrants, prevention is an important step. Part of preventive care is detecting illness at an early stage (for example by screening), so that treatment can be introduced when it works best (WHO Europe, 2018). However, screening of a population is only beneficial if a positive result leads to effective actions independent of geographic location (Jackson, 2017). So, how does one facilitate a fluid care pathway for TB-elimination? In the Netherlands, the Community Health Services (GGDs) carry out TB-control non-geographically. All 25 GGDs use iTBC, a nationwide, integrated platform that supports and connects all TB processes, independent of place and time. The appropriate TB screening pathway is selected, based on prevalence in country of birth, for all migrants resulting in optimized screening, treatment and control. In a PPP between Topicus, the Dutch Association of GGDs (GGD GHOR Nederland) and the Central Agency for the Reception of Asylum Seekers, this process has been automated for asylum seekers. By safely sharing relevant data, migrants can be screened and treated effectively. Resulting in health needs of migrants being met and optimum control of TB in low-incidence countries. The aim is to screen, treat, control and end tuberculosis whilst scaling the Dutch blueprint across the EU/EEA region. Key messages TB-screening contributes to EU public health if follow-up actions are facilitated non-geographically. The Dutch blueprint for TB-control shows how migrant health needs are met in an interconnected world.

Author(s):  
Bojana Čučković

The paper analyses the influence that the Covid-19 pandemic has had on the functioning of the European asylum system. The analysis is divided into three parts and addresses problematic issues associated with different stages of the pandemic. In the first part of the paper, the author outlines the asylum practices of EU Member States in the initial stage of the Covid-19 pandemic during which the pandemic was perceived as a state of emergency. By exploring the legal possibilities to derogate both from the EU asylum rules and international human rights standards, the author offers conclusions as regards limits of derogations and the legality of Member States’ practices, especially their failure to differentiate between rules that are susceptive of being derogated in emergency situations and those that are not. The second part of the paper analyses the current phase of the pandemic in which it is perceived as a 'new normal' and focuses on making the EU asylum system immune to Covid-19 influence to the greatest extent possible and in line with relevant EU and human rights rules. The author insists on the vulnerability as an inherent feature of persons in need of international protection and researches upon the relationship between the two competing interests involved – protection of asylum seekers and ensuring public health as a legitimate reason for restricting certain asylum seekers’ rights. The final part of the paper analyses the prospects of the future EU asylum system, as announced by the New Pact on Migration and Asylum in September 2020, to adapt to the exigencies of both the current Covid-19 crisis and pandemics that are yet to come. With an exclusive focus on referral to Covid-19 and provisions relevant for the current and future pandemics, the author criticizes several solutions included in the instruments that make up the Pact. It is concluded that the Pact failed to offer solutions for problems experienced during the Covid-19 pandemic and that, under the pretext of public health, it prioritizes the interests of Member States over the interests of applicants for international protection.


2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
A Filia ◽  
M C Rota ◽  
A Grossi ◽  
D Martinelli ◽  
T De Graaf ◽  
...  

Abstract Background National immunisation programmes depend on an adequate supply of vaccines but shortages have become more frequent globally in recent years. Vaccine shortages can lead to missed opportunities for vaccination and a greater risk of occurrence of vaccine-preventable diseases (VPD). Methods The EU-Joint Action on Vaccination is a European Commission-funded project* which aims to strengthen cooperation between European countries against VPDs, including improvement of vaccine supply and preparedness. In this context, from February to May 2019, we conducted a survey amongst persons in charge of national immunisation programmes or of vaccine supply/procurement in EU/EEA, to collect information on vaccine shortages in the previous three years. Results Twenty-one of 28 invited countries responded, of which 19 reported at least one shortage, for a total of 115 shortage events. The median number of shortages per country was 5 (range 0-15). At the time of survey completion, there were ongoing shortages in six countries. DT/dt-containing combination vaccines, hepatitis A, hepatitis B and BCG vaccines were the most frequently involved vaccines. Supply and production issues, and global shortage, were the most frequent causes. Median duration of shortages was five months; 34% caused a disruption in immunization services. Procurement and purchase methods varied by country. Only half of countries have recommendations or procedures in place to address shortages. Conclusions Vaccine shortages are a serious public health issue in the EU. Causes are complex and multifaceted and more research is needed to understand the economic and market-related causes. Improved communication between public health authorities, manufacturers and regulatory agencies is essential. Procurement and tender mechanisms should be improved. In case of vaccine shortages, all countries should have procedures or recommendation in place regarding the use of alternative vaccines or vaccination schedules. Key messages Vaccine shortages are a relevant public health issue in the EU. More research is needed on the complex and multifaceted causes of vaccine shortages. Timely communication between supply and demand is needed and procurement and tender mechanisms should be improved.


2000 ◽  
Author(s):  

Worldwide, one in eight pregnancy-related deaths result from complications of unsafe abortion such as bleeding, infection, or internal injuries. Many of these deaths could be prevented if women had the means to avoid unplanned pregnancy. At the 1994 United Nations International Conference on Population and Development, 180 governments identified postabortion care (PAC) as a high-priority public health issue. As part of the resulting global PAC initiative, the Population Council and other international organizations collaborated with governments and nongovernmental organizations in a worldwide program of operations research on interventions to improve postabortion care. This brief highlights the major findings of this research.


2016 ◽  
Vol 26 (3) ◽  
pp. 372-373 ◽  
Author(s):  
Jan C. Semenza ◽  
Paloma Carrillo-Santisteve ◽  
Herve Zeller ◽  
Andreas Sandgren ◽  
Marieke J. van der Werf ◽  
...  

Author(s):  
Silvia Maria De Almeida

Background and Objectives: Knowledge about species diversity of non-tuberculous mycobacteria (NTM) and the frequency of tuberculosis (TB) is an important issue in rural-urban regions such as Piauí (northeast of Brazil), of low incidence rate of TB , can help to improve diagnosis and prevention strategies. The aim of this study is to examine some epidemiological aspects and the frequency of Mycobacterium tuberculosis (Mtb) and NTM isolated at the central public health reference laboratory, Dr. Costa Alvarenga, Piauí (LACEN-PI). Methods: Data records of all mycobacterosis and tuberculosis cases from January 2014 to March 2015 were analyzed. Results : Of the 20% (142/706) positive growths, 70% (99) were Mtb and 10% NTM. The remainde was of inadequate clinical samples, not allowing the identification of even the suspected NTM. The most frequent clinical form was pulmonary with TB patients younger than those infected with NTM (p = 0.001), the majority living in Teresina (52%). NTMs identified were M. abscessus (36%), M. avium, M. intracellulare, Mycobacterium sp. (14% each) and M. asiaticum, M. szulgai, M. kansasii 7% (each). Mtb drug resistance (7.8%) and TB co-infection with the human immunodeficiency virus (HIV-TB) found to be high (49%, 19/39) . Conclusion: The frequencies of Mtb infection, drug resistance and HIV-TB co-infection are still underestimated and failures in the identification of NTM may decrease the actual frequency of these infections. Therefore, there is a need for improvements in TB control and in the diagnosis of NTMs in Piauí.


Sign in / Sign up

Export Citation Format

Share Document